Related Experiment Video

Updated: Jan 12, 2026

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

15.5K

PSMA-TTV as a point-of-care selector

Kunpeng Yang1, Wenjuan Sun2, Bao Wang1

  • 1Department of Thoracic Oncology Surgery II, Jilin Cancer Hospital, Changchun, China; Changchun University of Chinese Medicine, Changchun 130117, China.

The Lancet. Oncology
|October 30, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

1.1K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.7K

Related Experiment Videos

Last Updated: Jan 12, 2026

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

15.5K
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

1.1K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.7K

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

6.9K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.9K

Articles linked to this work by shared authors, journal, and citation graph.

Preoperative Prediction of Pituitary Adenoma Consistency Using Synthetic MRI and Virtual Magnetic Resonance Elastography.

Journal of magnetic resonance imaging : JMRI·2026

Synthesis and phase behavior of a dual-responsive graft amphiphilic polymer via a green one-pot condensation approach.

RSC advances·2026

Electrolyte Engineering for 5 V Lithium Metal Batteries.

Advanced materials (Deerfield Beach, Fla.)·2026

In situ dynamic modulation of zero-valent and low-valent copper ratio for constructing stable copper catalysts for acetylene hydrochlorination.

Journal of colloid and interface science·2026

Design, Synthesis, and Bioactivity of 2,4-Diphenylquinoline Derivatives as Novel 1-Deoxy-d-xylulose-5-phosphate Synthase Inhibitors.

Journal of agricultural and food chemistry·2026

Stabilizing Lattice Oxygen Redox Through Bicarbonate Pyrolysis-Driven Multifunctional Interface Engineering in Li-Rich Layered Oxides.

Small (Weinheim an der Bergstrasse, Germany)·2026

Local management of second ipsilateral breast cancer events after primary breast-conserving therapy: an international Delphi consensus.

The Lancet. Oncology·2026

Consensus statements from the first Gynecologic Cancer InterGroup Cervical Cancer Consensus Conference in Clinical Research.

The Lancet. Oncology·2026

Advancing oncology education in low-income and middle-income African settings: global insights for local action.

The Lancet. Oncology·2026

Intravesical cretostimogene grenadenorepvec oncolytic immunotherapy in high-risk, BCG-unresponsive, non-muscle-invasive bladder cancer with carcinoma in situ (BOND-003 Cohort C): a single-arm, phase 3 trial.

The Lancet. Oncology·2026

Postmastectomy chest wall radiotherapy for breast cancer (SUPREMO): 5-year quality-of-life results from a randomised, controlled, phase 3 trial.

The Lancet. Oncology·2026

Addition of irinotecan to chemoradiotherapy as preoperative treatment for locally advanced rectal cancer (ARISTOTLE): a multicentre, open-label, phase 3, randomised controlled trial.

The Lancet. Oncology·2026

Examining the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) Moderate Risk Cannabis Use Threshold Among a Sample of U.S. Military Veterans with Chronic Pain Who Report Medical Cannabis Use.

Substance use & misuse·2026

Cost-Effectiveness of the Remote Primary Care and Psychiatry Model (MAP-PSI) for Depression in Youth Living in Rural and Indigenous Communities.

Actas espanolas de psiquiatria·2026

Make diagnostic doubt visible in healthcare.

Future healthcare journal·2026

Development of a nursing-led psychotherapeutic programme to promote coping in adults living with cancer: a qualitative programme development study.

Journal of research in nursing : JRN·2026

[What is psychotherapy? An interdisciplinary proposal for a definition].

Der Nervenarzt·2026

Multimodal examination of the acute effects of cannabis on subjective and physiological stress-related outcomes: a randomized placebo-controlled laboratory study.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us